215 related articles for article (PubMed ID: 8361391)
1. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
Ismaeel NA
Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance of Haemophilus ducreyi.
Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
[TBL] [Abstract][Full Text] [Related]
4. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
[TBL] [Abstract][Full Text] [Related]
5. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.
Van Dyck E; Bogaerts J; Smet H; Tello WM; Mukantabana V; Piot P
Antimicrob Agents Chemother; 1994 Jul; 38(7):1647-8. PubMed ID: 7979300
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.
Taylor DN; Echeverria P; Hanchalay S; Pitarangsi C; Slootmans L; Piot P
J Clin Microbiol; 1985 Mar; 21(3):442-4. PubMed ID: 3872313
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi.
Roy-Leon JE; Lauzon WD; Toye B; Singhal N; Cameron DW
J Antimicrob Chemother; 2005 Sep; 56(3):552-8. PubMed ID: 16046468
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand.
Taylor DN; Pitarangsi C; Echeverria P; Panikabutra K; Suvongse C
J Infect Dis; 1985 Nov; 152(5):1002-6. PubMed ID: 3876396
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Etest with agar dilution for antimicrobial susceptibility testing of Haemophilus ducreyi.
Lagergård T; Frisk A; Trollfors B
J Antimicrob Chemother; 1996 Nov; 38(5):849-52. PubMed ID: 8961054
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.
Bilgeri YR; Ballard RC; Duncan MO; Mauff AC; Koornhof HJ
Antimicrob Agents Chemother; 1982 Oct; 22(4):686-8. PubMed ID: 6983858
[TBL] [Abstract][Full Text] [Related]
11. The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi.
Wall RA; Mabey DC; Bello CS; Felmingham D
J Antimicrob Chemother; 1985 Aug; 16(2):165-8. PubMed ID: 3877717
[TBL] [Abstract][Full Text] [Related]
12. Chancroid and granuloma inguinale.
Ronald AR; Plummer FA
Clin Lab Med; 1989 Sep; 9(3):535-43. PubMed ID: 2676322
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
Aldridge KE; Cammarata C; Martin DH
Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
Abeck D; Johnson AP; Dangor Y; Ballard RC
J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
[TBL] [Abstract][Full Text] [Related]
15. Haemophilus ducreyi is resistant to human antimicrobial peptides.
Mount KL; Townsend CA; Bauer ME
Antimicrob Agents Chemother; 2007 Sep; 51(9):3391-3. PubMed ID: 17620373
[TBL] [Abstract][Full Text] [Related]
16. [Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002].
Shen XZ; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Jiang M; Hu YY; Yang YH
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1335-9. PubMed ID: 15387940
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, clinical features, diagnosis and treatment of Haemophilus ducreyi - a disappearing pathogen?
Lewis DA
Expert Rev Anti Infect Ther; 2014 Jun; 12(6):687-96. PubMed ID: 24597521
[TBL] [Abstract][Full Text] [Related]
18. Failure of treatment for chancroid in Rwanda is not related to human immunodeficiency virus infection: in vitro resistance of Haemophilus ducreyi to trimethoprim-sulfamethoxazole.
Bogaerts J; Kestens L; Martinez Tello W; Akingeneye J; Mukantabana V; Verhaegen J; Van Dyck E; Piot P
Clin Infect Dis; 1995 Apr; 20(4):924-30. PubMed ID: 7795096
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility of Haemophilus ducreyi.
Hammond GW; Lian CJ; Wilt JC; Ronald AR
Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
[TBL] [Abstract][Full Text] [Related]
20. Comparison of antimicrobial susceptibility patterns of fifty-seven strains of Haemophilus ducreyi isolated in Amsterdam from 1978 to 1985.
Sturm AW
J Antimicrob Chemother; 1987 Feb; 19(2):187-91. PubMed ID: 3494720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
